For Researchers

Funding process

Adore fosters a dynamic research environment where innovative proposals are continuously developed and refined. Our agile funding process (outlined below) begins with an initial peer review during Focus Group meetings, ensuring that proposals meet high-quality standards. If a proposal demonstrates sufficient quality and alignment with Adore’s objectives, the leaders from the respective Focus Group present the 2-page summaries at the quarterly Focus Group Leaders meetings. During this session, proposals are evaluated based on set criteria (see fundingproces document in the Adore Focus groups sharepoint.).
Promising proposals are then invited to submit a more detailed 6-page document, which undergoes formal evaluation. This structured approach ensures that only the most promising projects receive support, aligning with Adore’s strategic mission to accelerate impact in neurodegenerative disorders and cancers through impactful research in:

  • Transformative Therapies
  • Biomarker Discovery & Advanced Diagnostics
  • Precision Medicine & Targeted Treatment Optimization

Do you have a Breakthrough Idea?

If your research has the potential to accelerate impact for both neurological and oncology patients, we want to hear from you. Connect with the Scientific Program Manager or a Focus Group Leader to explore funding opportunities.

For detailed guidelines on crafting a successful proposal and a comprehensive overview of our funding process, see below. You can find the fundingproces description, templates, and proposals in our pipeline on our sharepoint, follow the link to ask permission to join the sharepoint.

It is requested that the Adore Foundation is acknowledged in all articles, publications, and future grant applications.
Example: “This work was supported by the Adore Foundation and its benefactors; grant number [toekenningsnummer].”


Leadership Team

The Adore initiative is driven by a distinguished team of experts committed to advancing oncology and neurology research through synergistic advancement and collaboration.

Directors:​

  • Prof. Dr. Geert Kazemier: Provides strategic leadership in oncology research, guiding ADORE’s initiatives to push the boundaries of cancer treatment.​
  • Dr. Jort Vijverberg: Neurologist at Alzheimercenter Amsterdam, leading transformative research in neurology​

Scientific Directors:​

  • Prof. Dr. Maarten Bijlsma: Scientific Director of Cancer Center Amsterdam (CCA), leading efforts in cutting-edge cancer research.​
  • Prof. Dr. Guus Smit: Scientific Director of the Amsterdam Neuroscience Center (ANS), advancing pioneering work in neuroscience & representative of the Proteomics & Genomics Focus Group.​

Research Board:​

  • Prof. Dr. Yolande Pijnenburg: Medical Director, Alzheimer Center Amsterdam
  • Prof. Dr. Wiesje van der Flier: Scientific Director, Alzheimer Center Amsterdam
  • Prof. Dr. Hans van Goudoever: Board of Directors, Amsterdam UMC
  • Prof. Dr. Arjen Brussaard: Vice Dean of Valorization, Amsterdam UMC
  • Prof. Dr. Elga de Vries: Vice Dean of Research, Amsterdam UMC
  • Prof. Dr. Joep Killestein: Director MS center Amsterdam UMC
  • Dr. Filip Eftimov: Neurologist at Amsterdam UMC

Focus Group representatives in Research Board:​

  • Prof. Dr. Sonja Zweegman: Representative of the Clinical Research Support Focus Group
  • Prof. Dr. Hans Berkhof: Representative of the Biocomputation Focus Group
  • Dr. Pieter van Bokhoven: Representative of the Drug Discovery and Therapy Development Focus Group
  • Dr. Michiel Pegtel: Representative for Biobanking and Biomarkers Focus Group
  • Prof. Dr. Hanneke van Laarhoven: Representative for the Imaging Focus Group
  • Prof. Dr. Yvette van Kooyk: Representative for the Immuno- and Cellular Therapy Focus Group

Adore’s leadership, alongside a diverse group of focus group leaders and key academic figures, guides the initiative’s research agenda with a collaborative and innovative approach. This team drives Adore’s mission to deliver real-world impact through cutting-edge oncology and neurology research, while fostering the seamless integration of scientific, clinical, and industry perspectives for groundbreaking discoveries.​

Maak een afspraak